South Korea CSF Management Market Outlook to 2023

Region:Asia

Author(s):

Product Code:GDMECC2458DB

Download Sample Report download
Buy the Full ReportStarting from $4995
Published on

June 2017

Total pages

25

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $4995

About the Report

About the Report

South Korea CSF Management Market Outlook to 2023

Summary

GlobalData's new report, "South Korea CSF Management Market Outlook to 2023", provides key market data on theSouth Korea CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments-Hydrocephalus Shunts and Dura Substitutes.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for CSF Management market segments-Hydrocephalus Shunts and Dura Substitutes.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within theSouth Korea CSF Management market.

Key players covered include Integra LifeSciences Holdings Corp, Medtronic plc, DePuy Synthes Inc and Others.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

Products

Products

Neurology Devices, CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products, Radiosurgery, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, St. Jude Medical LLC, Boston Scientific Corp, DePuy Synthes Inc, LivaNova PLC, Stryker Corporation, Natus Medical Incorporated, Terumo Corp, Elekta AB, Integra LifeSciences Holdings Corp, B. Braun Melsungen AG, Nihon Kohden Corp, Accuray Inc, KARL STORZ GmbH & Co KG, MIZUHO Co., Ltd., W. L. Gore & Associates Inc, Sophysa SA


Companies

Medtronic Plc, Integra LifeSciences Holdings Corp, B. Braun Melsungen AG, W. L. Gore & Associates Inc, DePuy Synthes Inc, MIZUHO Co., Ltd.

Table of Contents

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 CSF Management Market Segmentation 4

2.3 Definitions of Markets Covered in the Report 5

3 CSF Management Market, South Korea 6

3.1 CSF Management Market, South Korea, Revenue ($m), 2009-2016 6

3.2 CSF Management Market, South Korea, Revenue ($m), 2016-2023 8

3.3 CSF Management Market, South Korea, Volume (Units), 2009-2016 10

3.4 CSF Management Market, South Korea, Volume (Units), 2016-2023 12

3.5 CSF Management Market, South Korea, Average Price ($), 2009-2023 14

3.6 CSF Management Market, South Korea, Distribution Share by Revenue ($m), 2015-2016 15

3.7 CSF Management Market, South Korea, Company Share by Revenue ($m), 2016 16

4 Overview of Key Companies in South Korea, CSF Management Market 18

4.1 Medtronic Plc 18

4.1.1 Company Overview 18

4.2 Integra LifeSciences Holdings Corp 18

4.2.1 Company Overview 18

4.3 B. Braun Melsungen AG 18

4.3.1 Company Overview 18

4.4 W. L. Gore & Associates Inc 18

4.4.1 Company Overview 18

4.5 DePuy Synthes Inc 19

4.5.1 Company Overview 19

4.6 MIZUHO Co., Ltd. 19

4.6.1 Company Overview 19

5 CSF Management Market Pipeline Products 20

6 Appendix 21

6.1 Research Methodology 22

6.1.1 Coverage 22

6.1.2 Secondary Research 22

6.1.3 Primary Research 23

6.1.4 Company Share Analysis 23

6.1.5 Distribution Share Analysis 23

6.1.6 Benchmarking 24

6.2 GlobalData Consulting 24

6.3 Contact Us 25

6.4 Disclaimer 25


List of Figure

1.2 List of Figures

Figure 1: CSF Management Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 6

Figure 2: CSF Management Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 8

Figure 3: CSF Management Market, South Korea, Volume (Units), Historic, 2009-2016 10

Figure 4: CSF Management Market, South Korea, Volume (Units), Forecast, 2016-2023 12

Figure 5: CSF Management Market, South Korea, Company Share (%) 2016 16


List of Table

1.1 List of Tables

Table 1: CSF Management Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 7

Table 2: CSF Management Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 9

Table 3: CSF Management Market, South Korea, Volume (Units), Historic, 2009-2016 11

Table 4: CSF Management Market, South Korea, Volume (Units), Forecast, 2016-2023 13

Table 5: CSF Management Market, South Korea, Average Price ($), Historic, 2009-2016 14

Table 6: CSF Management Market, South Korea, Average Price ($), Forecast, 2016-2023 14

Table 7: CSF Management Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2015-2016 15

Table 8: CSF Management Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016 17

Table 9: CSF Management Market Pipeline Products 20

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022